Peripheral blood progenitor cell transplantation in 118 patients with hematological malignancies: analysis of factors affecting the rate of engraftment.

Abstract

We retrospectively studied the factors affecting the rate of hematopoietic reconstitution (HR) in 118 patients with hematological malignancies who underwent peripheral blood progenitor cell (PBPC) transplantation at a single institution. The patients received a median number of 6.6 x 10(8) nucleated cells/kg corresponding to 9.5 x 10(4) (0.5-578) CFU-GM/kg and 6.8 x 10(6) (0.2-161) CD34-positive cells/kg. The median number of days to reach 500 polymorphonuclear cells/mm3 and 50,000 platelets/mm3 was 12.5 (6-93) and 14.5 (6-440) days, respectively. No patient died from infection during the aplastic phase. By multivariate analysis, we found that the dose of CFU-GM infused was the only factor that significantly affects the HR rate (p < 0.0001). Moreover, patients with acute myelogenous leukemia or those transplanted after busulfan or total-body irradiation conditioning regimens had a slower engraftment (p < 0.08). These results could lead to identifying patients who need growth factors posttransplantation and/or the reinfusion of "back-up" marrow together with PBPC.

• Authors: J Reiffers, C Faberes, J M Boiron, G Marit, C Foures, A M Ferrer, P Cony-Makhoul, M Puntous, P Bernard, G Vezon
• Journal: Journal of hematotherapy (J Hematother) Vol. 3 Issue 3 Pg. 185-91 ( 1994) ISSN: 1061-6128 [Print] United States
• PMID: 7530133 (Publication Type: Journal Article)

Chemical References

• Antigens, CD
• Antigens, CD34

Topics

• Actuarial Analysis
• Adolescent
• Adult
• Aged
• Antigens, CD
• Antigens, CD34
• Child
• Colony-Forming Units Assay
• Female
• Graft Survival
• Hematopoietic Stem Cell Transplantation
• Humans
• Leukemia (mortality, therapy)
• Lymphoma (mortality, therapy)
• Male
• Middle Aged
• Multiple Myeloma (mortality, therapy)
• Platelet Count
• Retrospective Studies
• Survival Rate
• Time Factors